These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19910556)

  • 21. New chemotherapy regimens for advanced bladder cancer.
    Fagbemi SO; Stadler WM
    Semin Urol Oncol; 1998 Feb; 16(1):23-9. PubMed ID: 9508079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic bladder cancer: advances in treatment.
    Stadler WM; Kuzel TM; Raghavan D; Levine E; Vogelzang NJ; Roth B; Dorr FA
    Eur J Cancer; 1997 Jan; 33 Suppl 1():S23-6. PubMed ID: 9166096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New drugs currently available in non-muscle invasive bladder cancer: update on gemcitabine studies.
    Gontero P; Fiorito C; Lucca I; Valentino F; Tizzani A
    Arch Ital Urol Androl; 2008 Dec; 80(4):162-6. PubMed ID: 19235433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of metastatic urothelial cancer in the post-MVAC era.
    Cohen EE; Stadler WM
    World J Urol; 2001 Apr; 19(2):126-32. PubMed ID: 11374315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ].
    Gligorov J; André T; Epaud C; Culine S
    Bull Cancer; 2002 Aug; 89 Spec No():S134-44. PubMed ID: 12449045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of gemcitabine in cancer therapy.
    Toschi L; Finocchiaro G; Bartolini S; Gioia V; Cappuzzo F
    Future Oncol; 2005 Feb; 1(1):7-17. PubMed ID: 16555971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and preclinical activity of 2',2'-difluorodeoxycytidine (gemcitabine).
    Lund B; Kristjansen PE; Hansen HH
    Cancer Treat Rev; 1993 Jan; 19(1):45-55. PubMed ID: 8431926
    [No Abstract]   [Full Text] [Related]  

  • 28. Antineoplastic effect of gemcitabine in an animal model of superficial bladder cancer.
    Nativ O; Dalal E; Laufer M; Sabo E; Aronson M
    Urology; 2004 Oct; 64(4):845-8. PubMed ID: 15491745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The not-infrequent story of a superficial bladder carcinoma...Discussion of clinical case no.2].
    Gontero P
    Arch Ital Urol Androl; 2006 Dec; 78(4 Suppl 1):11-2. PubMed ID: 17491550
    [No Abstract]   [Full Text] [Related]  

  • 30. Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer.
    Vogelzang NJ; Stadler WM
    Urology; 1999 Feb; 53(2):243-50. PubMed ID: 9933034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDA expands access to gemcitabine for pancreatic cancer.
    Am J Health Syst Pharm; 1995 May; 52(9):931. PubMed ID: 7641030
    [No Abstract]   [Full Text] [Related]  

  • 32. The antineoplastic treatment in the elderly.
    Vincenzi B; Santini D; Spoto S; Finolezzi E; D'Angelillo RM; La Cesa A; Tonini G
    Clin Ter; 2002; 153(3):207-15. PubMed ID: 12161983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gemcitabine in advanced bladder cancer].
    Lehmann J; Retz M; Lippert C; Albers P; Stöckle M
    Urologe A; 2003 Jan; 42(1):63-77. PubMed ID: 12574885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New drugs for cancer.
    Lippman AJ
    N J Med; 1998 Jul; 95(7):51-4. PubMed ID: 16013168
    [No Abstract]   [Full Text] [Related]  

  • 35. Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer.
    Galsky MD; Hahn NM; Powles T; Hellerstedt BA; Lerner SP; Gardner TA; Yu M; O'Rourke M; Vogelzang NJ; Kocs D; McKenney SA; Melnyk AM; Hutson TE; Rauch M; Wang Y; Asmar L; Sonpavde G
    Clin Genitourin Cancer; 2013 Jun; 11(2):175-81. PubMed ID: 23228446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New wave of chemotherapeutic agents: update in pulmonary oncology].
    Sculier JP
    Rev Mal Respir; 1997 Apr; 14(2):154-6. PubMed ID: 9198842
    [No Abstract]   [Full Text] [Related]  

  • 37. Gemcitabine in bladder cancer.
    Sternberg CN
    Semin Oncol; 2000 Feb; 27(1 Suppl 2):31-9. PubMed ID: 10697034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional p53 mutation as a molecular determinant of paclitaxel and gemcitabine susceptibility in human bladder cancer.
    Kielb SJ; Shah NL; Rubin MA; Sanda MG
    J Urol; 2001 Aug; 166(2):482-7. PubMed ID: 11458051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.
    Shelley M; Cleves A; Wilt TJ; Mason M
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008976. PubMed ID: 21491413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer.
    Borut K; Lijana ZK
    Radiother Oncol; 2012 Mar; 102(3):412-5. PubMed ID: 21890225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.